These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A case of malignant syndrome associated with a parkinsonism patient. Sanga M, Nomura S. Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Apr; 23(2):91-5. PubMed ID: 12762221 [Abstract] [Full Text] [Related]
5. [Significance of serum myosin light chain-1 level in neuroleptic malignant syndrome]. Konagaya M, Iida M, Konagaya Y. No To Shinkei; 1994 Apr; 46(4):373-8. PubMed ID: 8024837 [Abstract] [Full Text] [Related]
6. [Multiple system atrophy: an analytic study of 20 cases]. Xu XX. Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Feb; 22(1):29-31, 62. PubMed ID: 2805975 [Abstract] [Full Text] [Related]
15. [Neuroleptic malignant syndrome after aortic valve replacement; report of a case]. Ichiba T, Takemoto N. Kyobu Geka; 2003 Sep; 56(10):872-4. PubMed ID: 13677924 [Abstract] [Full Text] [Related]
16. In vivo models of multiple system atrophy. Fernagut PO, Ghorayeb I, Diguet E, Tison F. Mov Disord; 2005 Aug; 20 Suppl 12():S57-63. PubMed ID: 16092092 [Abstract] [Full Text] [Related]
17. [Multiple system atrophy with a-/hypo-ceruloplasminemia: distribution of iron in brains of 2 autopsy cases]. Kurisaki H, Yomono H, Murayama S, Hebisawa A. Rinsho Shinkeigaku; 2002 Apr; 42(4):293-8. PubMed ID: 12561083 [Abstract] [Full Text] [Related]
18. [Neuroleptic malignant syndrome in users of risperidone]. Gerritsen AA, de Jonghe-Rouleau AP, Stienstra-Liem LH. Ned Tijdschr Geneeskd; 2004 Sep 11; 148(37):1801-4. PubMed ID: 15495506 [Abstract] [Full Text] [Related]